Samenvatting
De behandeling van allergische rhinoconjunctivitis bestaat primair uit vermijding van het allergeen en symptomatische therapie. Als er ondanks maximale medicamenteuze therapie klachten blijven bestaan of indien medicamenteuze therapie niet mogelijk of gewenst is, kan immunotherapie overwogen worden. Specifieke immunotherapie met allergeenextracten heeft tot doel een allergische patiënt minder gevoelig te maken voor een specifiek allergeen (hyposensibilisatie). Voor kinderen met een therapieresistente inhalatieallergie is subcutane immunotherapie een effectieve behandeling die – mits protocollair uitgevoerd – veilig is. Als alternatief voor het maandelijks prikken zijn er inmiddels ook effectieve sublinguale toedieningsvormen ontwikkeld in de vorm van een smelttablet. Vooralsnog is deze toedieningsvorm echter alleen beschikbaar voor graspollenallergie.
Summary
Therapy for allergic rhino conjunctivitis exists of avoiding of contact with allergens and symptomatic therapy. For structural treatment immunotherapy can be considered. Immunotherapy with allergen extracts can be used to treat allergies by desensitisation. When performed by protocol subcutaneous immunotherapy is effective and safe in children with a therapy resistant inhalation allergy. As an alternative for the monthly injections sublingual tablets for sublingual immunotherapy have recently been proven to be effective. However, until now these tablets are only available for grass pollen allergy.
Literatuur
Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468–75
Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129:717–25
Röder E, Berger MY, Groot H de, Wijk RG van. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol. 2008;19:197–207
Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943– 8.
Jacobsen L,Wahn U, Bilo MB. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit – the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy. 2012;2:8.
Larenas-Linnemann DE, Pietropaolo-Cienfuegos DR, Calderón MA. Evidence of effect of subcutaneous immunotherapy in children: complete and updated review from 2006 onward. Ann Allergy Asthma Immunol. 2011;107:407–16
Bousquet J, Lockey RF, Malling HJ.WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998;53(suppl 44):1–42
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J. Allergy Clin Immunol. 2001;108:S147–334
Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol. 2009;123:167–73
Bufe A, Roberts G. Specific immunotherapy in children. Clin Exp Allergy. 2011;41:1256–62
Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2009;123:160–6
Groot H de, Bijl AMH. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy. 2009;64:963–4
Groot H de, Leer EHG van, Duijvestijn YCM. Immunotherapie op de kinderleeftijd. Tijdschr Kindergeneeskd. 2008;76:78–83
Eng PA, Borer-Reinhold M, Heijnen IAFM, Gnehm HPE. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy. 2006;61:198–201
Valovirta E, Berstad AK, de Blic J, et al. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis. Clin Ther. 2011;33: 1537–46
Author information
Authors and Affiliations
Additional information
kinderarts
kinderarts-allergoloog
allergoloog
Rights and permissions
About this article
Cite this article
Duijvestijn, Y.C.M., van Leer, E.H.G. & de Groot, H. Immunotherapie voor inhalatieallergenen op de kinderleeftijd. TIJDSCHR. KINDERGENEESKUNDE 80, 108–111 (2012). https://doi.org/10.1007/s12456-012-0031-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12456-012-0031-5